Literature DB >> 27347

[Salazosulfapyridine-induced lupus erythematosus syndrome in ulcerative colitis (author's transl)].

B H Jaup.   

Abstract

In a 25-year old woman with ulcerative colitis a lupus erythematosus syndrome occurred during treatment with salazosulfapyridine. The connection with medication was ascertained by reexposition. Some of the systemic complications of ulcerative colitis may possibly be due to the salazosulfapyridine medication.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 27347     DOI： 10.1055/s-0028-1129232

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


  4 in total

Review 1.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

2.  Sulphasalazine-induced systemic lupus erythematosus in a child.

Authors:  B A Vanheule; F Carswell
Journal:  Eur J Pediatr       Date:  1983-03       Impact factor: 3.183

Review 3.  Acetylator phenotype and lupus erythematosus.

Authors:  J P Uetrecht; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

4.  Sulphasalazine-induced systemic lupus erythematosus in a patient with Sjögren's syndrome.

Authors:  A J Crisp; B I Hoffbrand
Journal:  J R Soc Med       Date:  1980-01       Impact factor: 18.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.